ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,395
0,32%
Bitcoin
63 346,19
-1,02%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) Actualités

XRTX

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XRTX
DateHeureSourceTitreSymboleSociété
30/04/202419h54GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
22/04/202413h00GlobeNewswire Inc.XORTX Announces Publication of Key Research in ADPKDNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202413h30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202413h00GlobeNewswire Inc.XORTX Announces Participation in Spring 2024 Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
27/03/202410h00GlobeNewswire Inc.XORTX Announces New Clinical Advisory Board MemberNASDAQ:XRTXXORTX Therapeutics Inc
19/03/202410h00GlobeNewswire Inc.XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialNASDAQ:XRTXXORTX Therapeutics Inc
04/03/202413h00GlobeNewswire Inc.XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/02/202413h00GlobeNewswire Inc.XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
02/02/202402h46GlobeNewswire Inc.XORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/01/202413h00GlobeNewswire Inc.XORTX Announces $2 Million Public OfferingNASDAQ:XRTXXORTX Therapeutics Inc
03/01/202413h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
03/01/202413h00GlobeNewswire Inc.XORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202313h30GlobeNewswire Inc.XORTX Announces US ATM OfferingNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202303h57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
29/11/202313h00GlobeNewswire Inc.XORTX Meets Nasdaq Continued Listing RequirementsNASDAQ:XRTXXORTX Therapeutics Inc
10/11/202313h00GlobeNewswire Inc.XORTX Clarifies Timing for Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
08/11/202323h00GlobeNewswire Inc.XORTX Announces Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
02/11/202312h00GlobeNewswire Inc.XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
27/10/202323h30GlobeNewswire Inc.XORTX Announces Results of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202323h00GlobeNewswire Inc.XORTX Announces Date for Rescheduled Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202313h00GlobeNewswire Inc.XORTX Announces Rescheduling of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
12/10/202313h00GlobeNewswire Inc.XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation ResolutionNASDAQ:XRTXXORTX Therapeutics Inc
04/10/202313h00GlobeNewswire Inc.XORTX Calls Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
28/09/202313h00GlobeNewswire Inc.XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
11/09/202313h00GlobeNewswire Inc.XORTX Announces Participation at Upcoming Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
07/09/202313h00GlobeNewswire Inc.XORTX Joins the Kidney Foundation and Kidney MarchNASDAQ:XRTXXORTX Therapeutics Inc
29/08/202313h00GlobeNewswire Inc.XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
25/08/202312h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
08/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XRTXXORTX Therapeutics Inc
04/08/202323h00GlobeNewswire Inc.XORTX Appoints Chief Financial OfficerNASDAQ:XRTXXORTX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:XRTX

Dernières Valeurs Consultées

EU
ML
Michelin
EU
RNO
Renault
NASDAQ
MSFT
Microsoft
EU
GLE
Societe Generale
NYSE
JPM
JP Morgan Chase
EU
AF
Air FranceKLM
EU
CAP
Capgemini
EU
HO
Thales
FTSE
UKX
FTSE 100
EU
VK
Vallourec
EU
LR
Legrand
EU
RI
Pernod Ricard
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés